Dopamine

immunoglobulin heavy diversity 2-15 ; Homo sapiens







28 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35202123 Olfactory Bulb D2/D3 Receptor Availability after Intrastriatal Botulinum Neurotoxin-A Injection in a Unilateral 6-OHDA Rat Model of Parkinson's Disease. 2022 Jan 25 1
2 35573352 Case Report: Long-Acting Oral Cariprazine. 2022 1
3 34170848 Computational study on new natural compound agonists of dopamine receptor. 2021 Jun 25 1
4 32454148 Evolutionary conservation and functional impact of dopamine D2 receptor. 2020 Aug 10 4
5 32818617 Association of dopamine D2/3 receptor binding potential measured using PET and [11C]-(+)-PHNO with post-mortem DRD2/3 gene expression in the human brain. 2020 Dec 1
6 27241797 Prediction of striatal D2 receptor binding by DRD2/ANKK1 TaqIA allele status. 2016 Oct 1
7 27273047 Sulfation of the FLAG epitope is affected by co-expression of G protein-coupled receptors in a mammalian cell model. 2016 Jun 7 1
8 26156996 Chronic Back Pain Is Associated with Alterations in Dopamine Neurotransmission in the Ventral Striatum. 2015 Jul 8 1
9 22001575 Verification of expressions of Kir2 as potential peripheral biomarkers in lymphocytes from patients with Parkinson's disease. 2011 Nov 14 1
10 20302892 Binding of dopamine and 3-methoxytyramine as l-DOPA metabolites to human alpha(2)-adrenergic and dopaminergic receptors. 2010 Jul 1
11 11445186 Dopamine D2 receptor mediated presynaptic inhibition of striatopallidal GABA(A) IPSCs in vitro. 2001 Jul 1
12 11716810 Dopamine D2 receptor-mediated G-protein activation in rat striatum: functional autoradiography and influence of unilateral 6-hydroxydopamine lesions of the substantia nigra. 2001 Nov 30 2
13 10051542 G protein activation by human dopamine D3 receptors in high-expressing Chinese hamster ovary cells: A guanosine-5'-O-(3-[35S]thio)- triphosphate binding and antibody study. 1999 Mar 1
14 10430831 Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution. 1999 Aug 1
15 10431754 Actions of roxindole at recombinant human dopamine D2, D3 and D4 and serotonin 5-HT1A, 5-HT1B and 5-HT1D receptors. 1999 Jun 4
16 10455328 Comparison of the functional potencies of ropinirole and other dopamine receptor agonists at human D2(long), D3 and D4.4 receptors expressed in Chinese hamster ovary cells. 1999 Aug 1
17 9620058 Polymorphisms of dopamine receptor and transporter genes and Parkinson's disease. 1995 1
18 7915514 [Selective dopamine D-2 autoreceptor agonists with 8-azaindole substructure: synthesis and theoretical studies]. 1994 Jul 1
19 8104554 Dopamine receptor pharmacology. 1993 Aug 1
20 8328325 Neuroleptic malignant syndrome induced by nemonapride. 1993 Apr 1
21 22290999 Effect of chronic treatment with NNC 756, a new D-1 receptor antagonist, or raclopride, a D-2 receptor antagonist, in drug-naive Cebus monkeys: dystonia, dyskinesia and D-1/D-2 supersensitivity. 1993 Jan 1
22 1362452 In vivo evidence for a concordant response of terminal and dendritic dopamine release during intranigral infusion of drugs. 1992 Dec 2
23 1975636 D-2 dopamine autoreceptor selective drugs: do they really exist? 1990 1
24 2527290 Effects of D-2 antagonists on frequency-dependent stimulated dopamine overflow in nucleus accumbens and caudate-putamen. 1989 Sep 1
25 2715255 Determination of enantiomeric purity of the new D-2 dopamine agonist 2-(N-propyl-N-2-thienylethylamino)-5-hydroxytetralin (N-0437) by reversed-phase high-performance liquid chromatography after pre-column derivatization with D(+)-glucuronic acid. 1989 Jan 27 1
26 3261249 Behavioral and biochemical effect of chronic treatment with D-1 and/or D-2 dopamine agonists in MPTP monkeys. 1988 May 20 2
27 2950291 D-2 dopamine antagonist-like effects of SCH 23390 on A9 and A10 dopamine neurons. 1987 Mar 16 2
28 2961580 The D-2 agonist quinpirole releases striatal dopamine in vivo. 1987 Oct 6 1